Shandong Dongyue Organosilicon Materials (300821) Fundamentals 2026 — P/E 144.1x, Revenue Analysis | SniperIQ
Shandong Dongyue Organosilicon Materials (300821) is a CN-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥19.6B, trading at ¥16.30 on the SHZ. This SniperIQ fundamentals page covers Shandong Dongyue Organosilicon Materials's valuation (P/E 144.1x, P/B 3.8x), profitability (net margin 3.6%), revenue (¥3.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shandong Dongyue Organosilicon Materials's market cap?
Shandong Dongyue Organosilicon Materials (300821) has a market capitalization of approximately ¥19.6B, trading at ¥16.30 on the SHZ. Market cap moves with the live share price.
What is Shandong Dongyue Organosilicon Materials's P/E ratio?
Shandong Dongyue Organosilicon Materials's trailing twelve-month P/E ratio is 144.1x, with a price-to-book (P/B) of 3.8x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Shandong Dongyue Organosilicon Materials?
Shandong Dongyue Organosilicon Materials runs a net profit margin of 3.6%, a gross margin of 9.2%, and an operating margin of 3.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shandong Dongyue Organosilicon Materials generate?
Shandong Dongyue Organosilicon Materials reported revenue of ¥3.8B for fiscal year 2025, with net income of -¥19M and earnings per share (EPS) of -0.0161. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shandong Dongyue Organosilicon Materials pay a dividend?
Shandong Dongyue Organosilicon Materials offers a trailing dividend yield of about 0.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Shandong Dongyue Organosilicon Materials financially healthy?
Shandong Dongyue Organosilicon Materials carries a debt-to-equity ratio of 0.00x and a current ratio of 2.44x, with a market beta of 0.98. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shandong Dongyue Organosilicon Materials a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shandong Dongyue Organosilicon Materials (300821) the key facts are: market cap ¥19.6B, P/E 144.1x, revenue ¥3.8B, 52-week range 8.52-31. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Shandong Dongyue Organosilicon Materials's full fundamentals live
Get Shandong Dongyue Organosilicon Materials's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.